Clinical Trial Update: MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial of MRI-guided High Intensity Focused Ultrasound (HIFU) with ThermoDox for palliation of painful bone metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Bone Metastases
• Breast Cancer
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• ThermoDox (doxorubicin liposome)

Snippet

Sponsor: Imunon | Conditions: Painful Bone Metastases, Breast Carcinoma | Phase 2 | Status: WITHDRAWN